Exact Sciences
EXAS
$58.11
Share price
-0.85%
Change (1 day)
-38.82%
Change (1 year)
Categories
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.
Exact Sciences (EXAS) - Net assets
Net assets on the balance sheet as of December 2024 : S$3.22 Billion
According to Exact Sciences's latest financial reports the company has S$3.22 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Exact Sciences - Net assets on balance sheet (from 2001 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $S$3.26 B | -21.39% |
| 2023-12-31 | $S$4.15 B | 1.82% |
| 2022-12-31 | $S$4.07 B | -10.92% |
| 2021-12-31 | $S$4.57 B | 54.85% |
| 2020-12-31 | $S$2.95 B | -4.12% |
| 2019-12-31 | $S$3.08 B | 231.59% |
| 2018-12-31 | $S$0.93 B | 33.65% |
| 2017-12-31 | $S$0.69 B | 43.44% |
| 2016-12-31 | $S$0.48 B | 4.96% |
| 2015-12-31 | $S$0.46 B | 21.08% |
| 2014-12-31 | $S$0.38 B | 122.73% |
| 2013-12-31 | $S$0.17 B | 42.19% |
| 2012-12-31 | $S$0.12 B | 11.51% |
| 2011-12-31 | $S$0.10 B | 5.25% |
| 2010-12-31 | $S$0.10 B | 1100.8% |
| 2009-12-31 | $S$8.55 M | -345.88% |
| 2008-12-31 | $-S$3.48 Million | -138.45% |
| 2007-12-31 | $S$9.04 M | -60.55% |
| 2006-12-31 | $S$22.93 M | -44.05% |
| 2005-12-31 | $S$40.99 M | -33.84% |
| 2004-12-31 | $S$61.96 M | 198.26% |
| 2003-12-31 | $S$20.77 M | -68.78% |
| 2002-12-31 | $S$66.54 M | -39.04% |
| 2001-12-31 | $S$0.10 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | S$0.94 B | -70.81% | 🇺🇸 USA |
 | S$1.57 B | -51.05% | 🇺🇸 USA |
 | S$0.38 M | -99.99% | 🇺🇸 USA |
 | S$108.75 B | 3,272.64% | 🇫🇷 France |